As of my last update in October 2023, there is limited publicly available information regarding the chemical substance identified as CHMFL-ABL-039 with the CAS number 2304344-56-5. This compound may be a novel or less-studied chemical, potentially related to research in pharmaceuticals or materials science. Typically, substances like this may exhibit specific characteristics such as molecular structure, solubility, stability, and reactivity, which are crucial for understanding their applications and safety profiles. To obtain detailed information about its physical and chemical properties, including its molecular formula, boiling and melting points, and potential uses, it is advisable to consult specialized chemical databases, scientific literature, or safety data sheets. Additionally, researchers may need to conduct experimental studies to fully characterize the substance and assess its behavior under various conditions.

CHMFL-ABL-039

2304344-56-5: As of my last update in October 2023, there is limited publicly available information regarding the chemical substance identified as CHMFL-ABL-039 with the CAS number 2304344-56-5. This compound may be a novel or less-studied chemical, potentially related to research in pharmaceuticals or materials science. Typically, substances like this may exhibit specific characteristics such as molecular structure, solubility, stability, and reactivity, which are crucial for understanding their applications and safety profiles. To obtain detailed information about its physical and chemical properties, including its molecular formula, boiling and melting points, and potential uses, it is advisable to consult specialized chemical databases, scientific literature, or safety data sheets. Additionally, researchers may need to conduct experimental studies to fully characterize the substance and assess its behavior under various conditions.

CHMFL-abl-039 is a potent inhibitor of kinases that has shown promising results in the treatment of cancer. This analog of nalbuphine has been tested extensively in Chinese hamster ovary cells and has been found to inhibit tumor cell growth through apoptosis induction. CHMFL-abl-039 specifically targets protein kinases, which are enzymes that play a crucial role in regulating cellular processes such as cell division and differentiation. Inhibitors of these kinases have emerged as a new class of anticancer agents due to their ability to selectively target cancer cells while sparing healthy cells. CHMFL-abl-039 is currently being investigated for its potential use in the treatment of various types of cancer in humans.

CAS 2304344-56-5

CHMFL-ABL-039

CHMFL-abl-039

Ref: 3D-ESD34456